Clinical Report: Understanding Myopia Management Options: Stellest

Overview

{'clinical_data_source': 'Verify and cite the source for the reduction percentages.'}

Background

Myopia, or nearsightedness, is a growing public health concern, particularly among children. Effective management strategies are essential to mitigate its progression and associated complications. Recent advancements in myopia control, including the introduction of Stellest lenses, provide practitioners with new tools to address this issue.

Data Highlights

Key Findings

Clinical Implications

Optometrists should consider incorporating Stellest lenses into their myopia management protocols, as they offer a promising option for slowing myopia progression in children. Regular follow-ups are essential to ensure proper adaptation and to assess the effectiveness of the treatment.

Conclusion

Stellest spectacle lenses represent a significant advancement in myopia management, providing effective options for practitioners to help control myopia progression in children. Continued research and clinical practice will further define their role in comprehensive myopia care.

References

1. Fulmer P., Optometric Management, 2025 -- Understanding Myopia Management Options: Stellest
2. FDA Clears First Eyeglass Lenses to Slow Myopia, Ophthalmology Management, 2025
3. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial, JAMA Ophthalmology, 2025
4. Standard of Care - World Council of Optometry
5. Optometric Management — BUSINESS: Optical
6. Ophthalmology Management — FDA Clears First Eyeglass Lenses to Slow Myopia
7. optometric management — Understanding Myopia Management Options: MiSight and Orthokeratology
8. Optometric Management — Myopia: The Myth of Stabilization
9. Standard of Care - World Council of Optometry
10. Spectacle Lenses With Aspherical Lenslets for Myopia Control vs Single-Vision Spectacle Lenses: A Randomized Clinical Trial | Trials | JAMA Ophthalmology | JAMA Network
11. Published Study in Peer-Reviewed Journal Confirms Lasting Myopia Control with MiSight® 1 day Contact Lenses Post-Treatment | CooperVision